IP Library Assignment 069599/0614
Patent Assignment
Reel/Frame 069599/0614

Assignment of Assignor's Interest

Recorded: 2024-12-11 Pages: 27
Assignor
ACLARIS THERAPEUTICS, INC.
Executed: 2019-10-10
Assignee
EPI HEALTH, LLC
134 COLUMBUS ST, CHARLESTON, SOUTH CAROLINA, 29403
Covered Properties (3)
Stabilized Oxymetazoline Formulations and Their Uses
Patent: 9,801,857 →
Application: 14/737,360 →
Publication: US 2015/0359781
Stabilized Oxymetazoline Formulations and Their Uses
Application: 16/924,782 →
Publication: US 2021/0169855
Stabilized Oxymetazoline Formulations and Their Uses
Application: 18/073,419 →
Publication: US 2023/0346749
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jul 2, 2015
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; ZHANG, STEVEN; AHLUWALIA, GURPREET
To: ALLERGAN, INC.
Reel/Frame 035973/0574 →
Assignment of Assignor's Interest Dec 5, 2018
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 047681/0466 →
Assignment of Assignor's Interest Nov 1, 2019
From: ACLARIS THERAPEUTICS, INC.
To: EPI HEALTH, LLC
Reel/Frame 050905/0290 →
Security Interest Mar 14, 2022
From: EPI HEALTH, LLC
To: EVENING POST GROUP, LLC
Reel/Frame 059364/0509 →
Release of Security Interest Jan 11, 2023
From: EVENING POST GROUP, LLC
To: EPI HEALTH, LLC
Reel/Frame 062347/0129 →
Assignment of Assignor's Interest Dec 11, 2024
From: SARPOTDAR, PRAMOD; WARNER, KEVIN; AHLUWALIA, GURPREET; KUANG, AMY
To: ALLERGAN, INC.
Reel/Frame 069557/0245 →
Assignment of Assignor's Interest Dec 11, 2024
From: EPI HEALTH, LLC
To: MAYNE PHARMA LLC
Reel/Frame 069557/0372 →
Assignment of Assignor's Interest Dec 11, 2024
From: ALLERGAN, INC.
To: ACLARIS THERAPEUTICS, INC.
Reel/Frame 069557/0318 →